We are led by an experienced leadership team with a proven track record in the biopharmaceutical industry. Collectively, our leadership team has contributed to drug discovery and development as well as approval, launch and commercialization of multiple specialty medicines.

Polygon
Lynne Powell
Chief Executive Officer
Polygon
Dr. Kevin P. Malobisky
Chief Regulatory and Strategic Operations Officer
Polygon
Dr. Hristos Glavinas
Chief Scientific Officer
Polygon
Katalin Ferenczi
General Manager, Europe
Polygon
Nikki Whitfield
Vice President and Head of CMC
Polygon
Dr. Elizabeth Manning Duus
Executive Director, Clinical Development
Polygon
Ian Kauffman
Head of Finance